Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 10 (October)

1. Mammographic breast density as an intermediate phenotype for breast cancer.
   Lancet Oncol, 6(10): 798-808. [Abstract] [Full-text]
2. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
   Biochem Biophys Res Commun, 337(1): 224-31. [Abstract] [Full-text]
3. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
   Exp Cell Res, 310(1): 205-17. [Abstract] [Full-text]
4. Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness.
   Exp Cell Res, 310(1): 176-85. [Abstract] [Full-text]
5. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells.
   Exp Cell Res, 310(1): 152-65. [Abstract] [Full-text]
6. In vivo dosimetry with MOSFETs: dosimetric characterization and first clinical results in intraoperative radiotherapy.
   Int J Radiat Oncol Biol Phys, 63(3): 952-60. [Abstract] [Full-text]
7. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
   Int J Radiat Oncol Biol Phys, 63(3): 845-51. [Abstract] [Full-text]
8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
   Biochem Biophys Res Commun, 336(4): 1221-6. [Abstract] [Full-text]
9. Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells.
   Biochem Pharmacol, 70(9): 1277-87. [Abstract] [Full-text]
10. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer.
    Clin Chim Acta, 361(1): 104-11. [Abstract] [Full-text]
11. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    J Natl Cancer Inst, 97(19): 1428-37. [Abstract] [Full-text]
12. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    JAMA, 294(13): 1634-46. [Abstract] [Full-text]
13. Expression of c-kit in adenoid cystic carcinoma of the breast.
    Am J Clin Pathol, 124(5): 733-9. [Abstract] [Full-text]
14. Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells.
    J Toxicol Environ Health A, 68(21): 1833-40. [Abstract] [Full-text]
15. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study.
    BMJ, 331(7520): 807. [Abstract] [Full-text]
16. Reduced screening mammography among women with diabetes.
    Arch Intern Med, 165(18): 2090-5. [Abstract] [Full-text]
17. The influence of health status, age, and race on screening mammography in elderly women.
    Arch Intern Med, 165(18): 2083-8. [Abstract] [Full-text]
18. Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
    J Pathol, 207(3): 260-8. [Abstract] [Full-text]
19. Comorbidity and survival disparities among black and white patients with breast cancer.
    JAMA, 294(14): 1765-72. [Abstract] [Full-text]
20. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
    Cancer Gene Ther, 12(11): 890-9. [Abstract] [Full-text]
21. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.
    FEBS Lett, 579(25): 5535-41. [Abstract] [Full-text]
22. Breast cancer risk with postmenopausal hormonal treatment.
    Hum Reprod Update, 11(6): 545-60. [Abstract] [Full-text]
23. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
    Hum Reprod Update, 11(6): 561-73. [Abstract] [Full-text]
24. Current status of hormone therapy and breast cancer.
    Hum Reprod Update, 11(6): 541-3. [Abstract] [Full-text]
25. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
    Endocrinology, 146(11): 4917-25. [Abstract] [Full-text]
26. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
    Endocrinology, 146(11): 4905-16. [Abstract] [Full-text]
27. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Endocrinology, 146(11): 4609-18. [Abstract] [Full-text]
28. Juvenile papillomatosis of the breast in a male infant with Noonan syndrome, café au lait spots, and family history of breast carcinoma.
    Pediatr Blood Cancer, 45(7): 991-3. [Abstract] [Full-text]
29. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden.
    Int J Cancer, 117(5): 842-7. [Abstract] [Full-text]
30. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
    Int J Cancer, 117(5): 730-7. [Abstract] [Full-text]
31. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    Int J Cancer, 117(5): 746-54. [Abstract] [Full-text]
32. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
    JAMA, 294(15): 1925-33. [Abstract] [Full-text]
33. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    N Engl J Med, 353(16): 1673-84. [Abstract] [Full-text]
34. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
    N Engl J Med, 353(16): 1659-72. [Abstract] [Full-text]
35. Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines.
    Biochem Biophys Res Commun, 337(3): 779-83. [Abstract] [Full-text]
36. Use of selective serotonin reuptake inhibitors and the risk of breast cancer.
    Am J Epidemiol, 162(9): 835-8. [Abstract] [Full-text]
37. Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K.
    Exp Cell Res, 310(2): 270-81. [Abstract] [Full-text]
38. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
    Carcinogenesis, 26(11): 1975-7. [Abstract] [Full-text]
39. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells.
    Carcinogenesis, 26(11): 1934-9. [Abstract] [Full-text]
40. Assessment of DNA damage in target tumor cells after thermoablation in mice.
    Radiology, 237(2): 500-6. [Abstract] [Full-text]
41. Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study.
    Radiology, 237(2): 444-9. [Abstract] [Full-text]
42. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
    Radiology, 237(2): 437-43. [Abstract] [Full-text]
43. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
    Radiology, 237(2): 429-36. [Abstract] [Full-text]
44. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer.
    Anesth Analg, 101(5): 1427-32. [Abstract] [Full-text]
45. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
    Histopathology, 47(5): 458-66. [Abstract] [Full-text]
46. Forequarter amputation for recurrent breast cancer: a case report and review of the literature.
    J Surg Oncol, 92(2): 134-41. [Abstract] [Full-text]
47. Surgeon perspectives about local therapy for breast carcinoma.
    Cancer, 104(9): 1854-61. [Abstract] [Full-text]
48. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
    Cancer, 104(9): 1834-9. [Abstract] [Full-text]
49. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Cancer, 104(9): 1840-8. [Abstract] [Full-text]
50. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
    Cancer, 104(9): 1849-53. [Abstract] [Full-text]
51. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification.
    Cancer, 104(9): 1862-70. [Abstract] [Full-text]
52. Serum lipids, lipid-lowering drugs, and the risk of breast cancer.
    Arch Intern Med, 165(19): 2264-71. [Abstract] [Full-text]
53. Optical transillumination spectroscopy to quantify parenchymal tissue density: an indicator for breast cancer risk.
    Br J Radiol, 78(935): 1009-17. [Abstract] [Full-text]
54. Clinical characteristics of different histologic types of breast cancer.
    Br J Cancer, 93(9): 1046-52. [Abstract] [Full-text]
55. Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients.
    Int J Cancer, 117(6): 961-73. [Abstract] [Full-text]
56. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
    Int J Cancer, 117(6): 988-91. [Abstract] [Full-text]
57. Is birth history the key to highly educated women's higher breast cancer mortality? A follow-up study of 500,000 women aged 35-54.
    Int J Cancer, 117(6): 1002-6. [Abstract] [Full-text]
58. Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.
    Int J Cancer, 117(6): 934-41. [Abstract] [Full-text]
59. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Mol Endocrinol, 19(11): 2660-70. [Abstract] [Full-text]
60. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
    Mol Endocrinol, 19(11): 2713-35. [Abstract] [Full-text]
61. Effect of screening and adjuvant therapy on mortality from breast cancer.
    N Engl J Med, 353(17): 1784-92. [Abstract] [Full-text]
62. Diagnostic performance of digital versus film mammography for breast-cancer screening.
    N Engl J Med, 353(17): 1773-83. [Abstract] [Full-text]
63. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
    Br J Surg, 92(11): 1363-7. [Abstract] [Full-text]
64. Breast-conserving surgery with resection of the nipple-areola complex for subareolar breast carcinoma.
    Br J Surg, 92(11): 1368-71. [Abstract] [Full-text]
65. Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study.
    Cancer Chemother Pharmacol, 56(5): 487-91. [Abstract] [Full-text]
66. Characterization of two new variants of human catechol O-methyltransferase in vitro.
    Cancer Lett, 230(1): 81-9. [Abstract] [Full-text]
67. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    J Clin Oncol, 23(31): 8025-32. [Abstract] [Full-text]
68. Recruiting African American women to participate in hereditary breast cancer research.
    J Clin Oncol, 23(31): 7967-73. [Abstract] [Full-text]
69. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    J Clin Oncol, 23(31): 7842-8. [Abstract] [Full-text]
70. Breast cancer trends among black and white women in the United States.
    J Clin Oncol, 23(31): 7836-41. [Abstract] [Full-text]
71. Squamous cell carcinoma of the breast.
    J Clin Oncol, 23(31): 7827-35. [Abstract] [Full-text]
72. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
    J Clin Oncol, 23(31): 7820-6. [Abstract] [Full-text]
73. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
    J Clin Oncol, 23(31): 7811-9. [Abstract] [Full-text]
74. Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.
    Lancet Oncol, 6(11): 886-98. [Abstract] [Full-text]
75. Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model.
    Lancet Oncol, 6(11): 856-63. [Abstract] [Full-text]
76. Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.
    Lancet, 366(9496): 1554-7. [Abstract] [Full-text]
77. Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma.
    J Am Coll Surg, 201(5): 688-94. [Abstract] [Full-text]
78. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    J Clin Oncol, 23(31): 7804-10. [Abstract] [Full-text]
79. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
    J Clin Oncol, 23(31): 7849-56. [Abstract] [Full-text]
80. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
    J Clin Oncol, 23(31): 7794-803. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.